Edgewell Q4 net sales +3.8% to $537M; FY GAAP EPS $0.53, adj. $2.52; sells Feminine Care for $340M

EDGEWELL PERSONAL CARE Co

2025-FY EPS reported $0.53 revenue$2,223,500,000

Q4 net sales $537.2M (+3.8% reported, +2.5% organic); FY net sales $2,223.5M (-1.3% both reported and organic).
GAAP diluted EPS $(0.66) for Q4, $0.53 for FY; adjusted EPS $0.68 for Q4, $2.52 for FY.
Board declared $0.15/share quarterly dividend and authorized new $100M share repurchase program.
Definitive agreement to sell Feminine Care business to Essity for $340 million; proceeds expected to reduce leverage.
Ended Q4 with $225.7M cash; net debt leverage ratio of 3.9x.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001628280-25-051816
form_type: 8-K
ticker: EPC
cik: 0001096752
company_name: EDGEWELL PERSONAL CARE Co
filed_at: 2025-11-13T23:59:59+00:00
discovered_at: 2026-05-14T18:02:38.787422+00:00
generated_at: 2026-05-16T20:07:59.101285+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: neutral
materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001628280-25-051816
json_url: https://secwatch.observer/filing/0001628280-25-051816.json
markdown_url: https://secwatch.observer/filing/0001628280-25-051816.md
text_url: https://secwatch.observer/filing/0001628280-25-051816.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1096752/000162828025051816/0001628280-25-051816-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1096752/000162828025051816/epc-20251113.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001628280-25-051816

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.